Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.73
+3.46 (1.69%)
AAPL  272.38
+6.19 (2.33%)
AMD  213.58
+16.98 (8.64%)
BAC  50.50
-0.57 (-1.12%)
GOOG  310.89
-0.80 (-0.26%)
META  639.45
+2.20 (0.35%)
MSFT  387.69
+3.21 (0.84%)
NVDA  192.74
+1.19 (0.62%)
ORCL  146.14
+4.83 (3.42%)
TSLA  408.95
+9.12 (2.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.